Novavax
NVAX
#5200
Rank
ยฃ1.28 B
Marketcap
ยฃ7.82
Share price
1.45%
Change (1 day)
23.06%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -ยฃ0.17 Billion

According to Novavax's latest financial reports the company's current earnings are ยฃ0.41 Billion. In 2025 the company made an earning of ยฃ0.34 Billion, an increase over its 2024 earnings that were of -ยฃ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.17 Billion-148.07%
2025 ยฃ0.34 B-396.87%
2024 -ยฃ0.12 Billion-70.39%
2023 -ยฃ0.4 Billion-16.59%
2022 -ยฃ0.48 Billion-62.58%
2021 -ยฃ1.27 Billion320.54%
2020 -ยฃ0.31 Billion234.22%
2019 -ยฃ89.96 Million-30.17%
2018 -ยฃ0.13 Billion1.69%
2017 -ยฃ0.13 Billion-36.44%
2016 -ยฃ0.2 Billion70.4%
2015 -ยฃ0.12 Billion89.27%
2014 -ยฃ61.8 Million59.83%
2013 -ยฃ38.67 Million81.9%
2012 -ยฃ21.26 Million50.33%
2011 -ยฃ14.14 Million
2009 -ยฃ27.91 Million8.8%
2008 -ยฃ25.65 Million18.01%
2007 -ยฃ21.74 Million18.33%
2006 -ยฃ18.37 Million168.31%
2005 -ยฃ6.85 Million-62.51%
2004 -ยฃ18.27 Million52.4%
2003 -ยฃ11.99 Million-28.21%
2002 -ยฃ16.7 Million
2000 -ยฃ9.52 Million177%
1999 -ยฃ3.44 Million-11.54%
1998 -ยฃ3.89 Million10.64%
1997 -ยฃ3.51 Million-9.62%
1996 -ยฃ3.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
ยฃ11.58 B-7,047.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ5.15 B-3,191.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.69 B-6,514.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ5.88 B-3,631.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-ยฃ97.73 Million-41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.25 Billion 45.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ0.11 B-167.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-ยฃ6.04 Million-96.38%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ0.29 Billion 70.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-ยฃ70.99 Million-57.43%๐Ÿ‡บ๐Ÿ‡ธ USA